Impact of Endometriosis on Pregnancy and Delivery - a Retrospective Cohort Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04664335 |
|
Recruitment Status :
Completed
First Posted : December 11, 2020
Last Update Posted : December 11, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Purpose:
To study the impact of endometriosis on subsequent pregnancy and delivery.
Methods:
retrospective analysis by questionnaire / interview of cases (endometriosis laparoscopically removed / child wish) vs. controls (endometriosis laparoscopically excluded / child wish) from the University Hospital Muenster, Germany, treated between 2009 and 2016; analysis of pregnancy rate, mode of delivery and complications using Clavien-Dindo-classification, role of deep infiltrating endometriosis using ENZIAN classification; data analysis using t-test with p < 0.050% being considered significant.
| Condition or disease | Intervention/treatment |
|---|---|
| Endometriosis Pregnancy Complications Delivery Complication Complication Miscarriage | Other: questionnaire |
| Study Type : | Observational |
| Actual Enrollment : | 1762 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | Impact of Endometriosis on Pregnancy and Delivery - a Retrospective Cohort Study |
| Actual Study Start Date : | January 2016 |
| Actual Primary Completion Date : | October 2019 |
| Actual Study Completion Date : | November 2019 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
endometriosis cases
endometriosis laparoscopically removed / child wish
|
Other: questionnaire
if no Reply to questionnaire, telephone interview
Other Name: interview |
|
controls
endometriosis laparoscopically excluded / child wish
|
Other: questionnaire
if no Reply to questionnaire, telephone interview
Other Name: interview |
- pregnancy rate [ Time Frame: through study completion, an average of 1 year ]pregnancy rate
- complications [ Time Frame: through study completion, an average of 1 year ]complications during pregnancy, delivery, puerperium
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 50 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- cases: Operation because of endometriosis at the endometriosis Center, University Hospital Muenster, child wish, wants to participate, correct age group
- controls: Operation because of sterility, exclusion of endometriosis during this Operation, child wish, wants to participate, correct age group
Exclusion Criteria:
- cases / controls: declines participation, incorrect age Group, no child wish
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04664335
| Principal Investigator: | Sebastian D Schaefer, MD PhD | University Hospital Muenster, Germany |
| Responsible Party: | Dr. med. Sebastian Daniel Schäfer, Head of Gynecology, University Hospital Muenster |
| ClinicalTrials.gov Identifier: | NCT04664335 |
| Other Study ID Numbers: |
Schäfer_Endo_Preg_Del_Comp |
| First Posted: | December 11, 2020 Key Record Dates |
| Last Update Posted: | December 11, 2020 |
| Last Verified: | December 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Plan Description: | will share upon reasonable request according to regulations |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
endometriosis pregnancy delivery miscarriage cesarian section |
|
Endometriosis Abortion, Spontaneous Pregnancy Complications |

